PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.756
EU - Europa 9.961
AS - Asia 7.901
SA - Sud America 1.109
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
Totale 36.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.511
GB - Regno Unito 3.413
IT - Italia 2.954
CN - Cina 2.509
SG - Singapore 2.295
HK - Hong Kong 935
VN - Vietnam 869
BR - Brasile 838
SE - Svezia 707
DE - Germania 547
UA - Ucraina 487
FI - Finlandia 429
FR - Francia 408
RU - Federazione Russa 287
KR - Corea 279
TR - Turchia 273
NL - Olanda 213
BG - Bulgaria 170
IN - India 145
CA - Canada 130
ID - Indonesia 121
AR - Argentina 87
BD - Bangladesh 87
IE - Irlanda 75
MX - Messico 70
IQ - Iraq 50
JP - Giappone 49
EC - Ecuador 47
CO - Colombia 41
ZA - Sudafrica 41
ES - Italia 38
BE - Belgio 37
PK - Pakistan 36
AE - Emirati Arabi Uniti 35
CH - Svizzera 30
CL - Cile 30
PL - Polonia 29
AT - Austria 28
MA - Marocco 26
VE - Venezuela 25
IR - Iran 24
MY - Malesia 20
PH - Filippine 19
BY - Bielorussia 18
TN - Tunisia 18
NP - Nepal 16
UZ - Uzbekistan 16
DZ - Algeria 15
EU - Europa 13
PY - Paraguay 13
SA - Arabia Saudita 13
IL - Israele 12
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SN - Senegal 12
TH - Thailandia 12
EG - Egitto 11
KE - Kenya 10
NO - Norvegia 10
UY - Uruguay 10
AU - Australia 9
ET - Etiopia 9
JO - Giordania 9
LB - Libano 9
CR - Costa Rica 8
GE - Georgia 8
KZ - Kazakistan 8
PT - Portogallo 8
TW - Taiwan 7
AO - Angola 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
PA - Panama 6
RS - Serbia 6
YE - Yemen 6
AL - Albania 5
AZ - Azerbaigian 5
BH - Bahrain 5
GR - Grecia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
DK - Danimarca 4
HU - Ungheria 4
NI - Nicaragua 4
PR - Porto Rico 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
EE - Estonia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
Totale 36.885
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Fairfield 1.719
Santa Clara 1.706
Ashburn 1.659
Singapore 1.410
Woodbridge 1.392
Jacksonville 1.008
Houston 970
Hefei 922
Hong Kong 913
Chandler 798
Dearborn 640
Wilmington 635
Seattle 593
Cambridge 573
Ann Arbor 561
Beijing 459
London 393
Nyköping 361
San Jose 304
Chicago 278
Helsinki 272
Ho Chi Minh City 272
Milan 268
Los Angeles 267
Seoul 261
The Dalles 256
Hanoi 216
Princeton 197
Modena 195
Council Bluffs 176
San Diego 175
Sofia 166
Eugene 162
Rome 152
Lauterbourg 148
Izmir 142
New York 137
Buffalo 130
Dallas 107
Moscow 105
Salt Lake City 87
Jakarta 78
Shanghai 71
Redwood City 69
Des Moines 68
Dublin 68
Turin 66
Naples 63
Bologna 62
São Paulo 62
Orem 59
Tokyo 43
Columbus 40
Haiphong 39
Tampa 38
Da Nang 37
Elk Grove Village 37
Nanjing 37
Rio de Janeiro 37
Genoa 36
Palermo 36
Frankfurt am Main 35
Brooklyn 34
Brussels 34
Dong Ket 33
Florence 33
Verona 33
Brescia 32
Ottawa 32
Phoenix 32
Bianco 29
Norwalk 29
Toronto 29
Bremen 28
Paris 28
Atlanta 27
Boardman 27
Falkenstein 27
Guangzhou 27
Lancaster 27
Chennai 26
Falls Church 26
Munich 26
Mexico City 25
Catania 24
Miami 23
Parma 22
Sterling 22
Tulare 21
Baghdad 20
Fremont 20
Jinan 20
Perugia 20
Philadelphia 20
Warsaw 20
Johannesburg 19
Denver 18
Montreal 18
Bari 17
Totale 25.886
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.144
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 785
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 409
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 396
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 359
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 344
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 343
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 342
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 334
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 329
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 309
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 307
Basal cutaneous pain threshold in headache patients 304
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 303
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 303
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 303
A case-control study of visually evoked postural responses in childhood with primary headaches 303
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 301
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 298
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 297
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 294
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 285
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 284
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 279
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 273
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 272
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 270
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 269
Long-term follow-up of patients treated for chronic headache with analgesic overuse 266
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 266
Effect of rofecoxib on nociception and the serotonin system in the rat brain 263
Headaches associated with chronic use of analgesics: A therapeutic approach 261
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 261
Disposition of naproxen after oral administration during and between migraine attacks. 260
Italian guidelines for primary headaches: 2012 revised version. 260
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 257
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 254
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 253
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 252
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 251
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 249
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 249
Analgesic abuse in chronic headache sufferers 247
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 246
Phenytoin-Treatment Of Rdeb Vegetans 245
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 243
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 243
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 243
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 242
An unusual case report on the possible role of Warfarin in migraine prophylaxis 242
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 241
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 239
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 238
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 235
Risk-benefit and cost-benefit ratio in headache treatment 234
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 231
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 230
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 230
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 227
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 226
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 224
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 224
Plasma glutathione level in chronic headache drug abuser patients 222
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 222
Nimodipine in otolaryngology: from past evidence to clinical perspectives 222
An emerging problem in clinical practice: how to treat chronic headache patients. 219
Relevance of analgesic abuse in the maintenance of chronic headaches 218
Triptans: the experience of a clinical pharmacologist in clinical practice. 217
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 217
Chronic daily headache: how to manage it? 216
Different characteristics of triptans 215
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 215
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 215
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 213
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 212
Analysis on the use of migraine preventative drugs in current clinical practice 211
Homocysteine levels and cardiovascular disease in migraine with aura 211
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 211
High prevalence of patent foramen ovale in migraine with aura 210
Tacrolimus pharmacokinetics in kidney transplant recipients. 209
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 209
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 208
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 208
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 208
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 206
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 205
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 204
Active reporting scheme: an example to evaluate specific adverse drug reactions. 203
Naloxone-reverisble antinociception by paracetamol in the rat. 202
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 202
Urinary neopterin in malignant lymphoma 201
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 200
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 199
Circadian variations of proopiocortin-related peptides in children with migraine. 198
PHARMACOKINETICS OF NAPROXEN AFTER ORAL-ADMINISTRATION DURING AND OUT OF MIGRAINE ATTACKS 196
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 196
Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study. 196
A CB1 agonist in the treatment of medication-overuse headache: a possible therapeutic strategy 196
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 195
The genetics of chronic headaches. 193
Totale 27.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021358 0 0 0 0 0 0 0 0 0 0 190 168
2021/20222.935 92 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/202610.067 716 540 1.207 1.289 1.331 822 1.203 664 1.084 947 264 0
Totale 37.029